Dyne Therapeutics Inc’s recent filing unveils that its Officer Scalzo Richard William acquired Company’s shares for reported $19619.0 on Jun 11 ’25. In the deal valued at $14.75 per share,1,330 shares were bought.
Then, Beskrovnaya Oxana bought 2,132 shares, generating $31,449 in total proceeds.
Before that, Cox John sold 4,060 shares. Dyne Therapeutics Inc shares valued at $54,201 were divested by the CEO & President at a price of $13.35 per share. As a result of the transaction, Cox John now holds 142,179 shares, worth roughly $1.19 million.
Bernstein initiated its Dyne Therapeutics Inc [DYN] rating to a Mkt perform in a research note published on June 24, 2025; the price target was $13. Evercore ISI started covering the stock on May 29, 2025. It rated DYN as “an Outperform”.
Price Performance Review of DYN
On Tuesday, Dyne Therapeutics Inc [NASDAQ:DYN] saw its stock jump 2.57% to $8.39. Over the last five days, the stock has lost -11.87%. Dyne Therapeutics Inc shares have fallen nearly -75.39% since the year began. Nevertheless, the stocks have fallen -64.39% over the past one year. While a 52-week high of $47.45 was reached on 01/02/25, a 52-week low of $6.36 was recorded on 04/09/25.
Levels Of Support And Resistance For DYN Stock
The 24-hour chart illustrates a support level at 8.21, which if violated will result in even more drops to 8.04. On the upside, there is a resistance level at 8.61. A further resistance level may holdings at 8.84.
How much short interest is there in Dyne Therapeutics Inc?
A steep rise in short interest was recorded in Dyne Therapeutics Inc stocks on 2025-06-13, dropping by -2.58 million shares to a total of 20.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 23.2 million shares. There was a decline of -12.5%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 12, 2025 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.
